IN2013MU03613A - - Google Patents

Download PDF

Info

Publication number
IN2013MU03613A
IN2013MU03613A IN3613MU2013A IN2013MU03613A IN 2013MU03613 A IN2013MU03613 A IN 2013MU03613A IN 3613MU2013 A IN3613MU2013 A IN 3613MU2013A IN 2013MU03613 A IN2013MU03613 A IN 2013MU03613A
Authority
IN
India
Prior art keywords
pemetrexed
less
oxygen less
2ppm
ready
Prior art date
Application number
Inventor
Kumar Mandal Jayanta
Pareshbhai Mehta Sandip
Original Assignee
Ftf Pharma Private Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ftf Pharma Private Ltd filed Critical Ftf Pharma Private Ltd
Priority to IN3613MU2013 priority Critical patent/IN2013MU03613A/en
Publication of IN2013MU03613A publication Critical patent/IN2013MU03613A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to pharmaceutical composition comprising pemetrexed, a ready to use injection comprising pemetrexed. Liquid composition of pemetrexed comprises head space oxygen less than 5%, dissolved oxygen less than 2ppm and individual impurity level less than 0.2%.
IN3613MU2013 2013-11-18 2013-11-18 IN2013MU03613A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN3613MU2013 IN2013MU03613A (en) 2013-11-18 2013-11-18

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3613MU2013 IN2013MU03613A (en) 2013-11-18 2013-11-18

Publications (1)

Publication Number Publication Date
IN2013MU03613A true IN2013MU03613A (en) 2015-07-31

Family

ID=54397601

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3613MU2013 IN2013MU03613A (en) 2013-11-18 2013-11-18

Country Status (1)

Country Link
IN (1) IN2013MU03613A (en)

Similar Documents

Publication Publication Date Title
PH12017500281A1 (en) Pyrrolopyrimidine compounds used as tlr7 agonist
MX365939B (en) Nuclear transport modulators and uses thereof.
MD20170016A2 (en) Aminopyrimidinyl compounds as JAK inhibitors
MX2016016666A (en) Boronic acid derivatives and therapeutic uses thereof.
MX2016015093A (en) Boronic acid derivatives and therapeutic uses thereof.
PH12015500850A1 (en) Stable preservative-free mydriatic and anti-inflammatory solutions for injection
NZ760790A (en) Pharmaceutical compositions comprising an antipsychotic drug and a vmat2 inhibitor and uses thereof
NZ720478A (en) Autotaxin inhibitor compounds
PH12015501753A1 (en) Enhanced stability of novel liquid compositions
MX2015009106A (en) Solid solution compositions and use in severe pain.
MD20140072A2 (en) New pyrrole compounds, process for their preparation and pharmaceutical compositions containing them
PH12018500377A1 (en) Novel annelated benzamides
CL2015002897A1 (en) Bace1 inhibitors
PH12018500378B1 (en) Novel annelated phenoxyacetamides
MY168212A (en) A new therapeutical composition containing apomorphine as active ingredient
EA201790726A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ULCERAL COLITIS
NZ710291A (en) 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine derivatives, use thereof as medicaments, and pharmaceutical compositions
MX2017006709A (en) Agent for preventing or improving symptoms caused by imbalance of sex hormones.
MX2017012596A (en) A pharmaceutical composition and the use thereof.
MX368635B (en) Tricyclic piperidine compounds.
MX2015003034A (en) Syringe containing a composition, especially a pharmaceutical composition, comprising immunoglobins, method for the production thereof and use of same.
MX363458B (en) Novel tetrazolone derivatives.
WO2015044434A3 (en) Fluor-9-methyl-β-carbolines
IN2013MU03613A (en)
MX2017008497A (en) Novel heterocyclic compounds and the use thereof in medicine and in cosmetics.